| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/19/2009 | US20090076087 Deuterium-enriched etoricoxib |
| 03/19/2009 | US20090076085 Deuterium-enriched nicraven |
| 03/19/2009 | US20090076081 Piperidine derivatives as nk3 antagonists |
| 03/19/2009 | US20090076078 New compounds 966 |
| 03/19/2009 | US20090076075 Quinoline derivatives |
| 03/19/2009 | US20090076074 Quinoline derivatives |
| 03/19/2009 | US20090076064 Compounds |
| 03/19/2009 | US20090076063 Carboxamide compound and use of the same |
| 03/19/2009 | US20090076026 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects of dry-mouth and constipation; biphenyl carbamate derivatives; biphenyl-2-ylcarbamic acid 1-(3-(3-[3-(4-hydroxybenzylamino)propyl]-2-oxoimidazolidin-1-yl)propyl)piperidin-4-yl ester |
| 03/19/2009 | US20090076020 Cyclopropyl Amide Derivatives 978 |
| 03/19/2009 | US20090076012 Modulation of pathogenicity |
| 03/19/2009 | US20090076009 Thiazole derivatives and their use as anti-tumour agents |
| 03/19/2009 | US20090076004 1-Aryl-or heteroaryl-3-aryl-or heteroarylindole-2-carboxylic acids or esters: e.g., 5-(4-tert-Butylphenyl)-1,3-bis(4-isopropoxyphenyl)-indole-2-carboxylic acid; inhibition of the activity of microsomal prostaglandin E synthase-1, leukotriene C4 and/or 5-lipoxygenase-activating protein; analgesics |
| 03/19/2009 | US20090076003 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 03/19/2009 | US20090075988 phosphodiesterase inhibitors such as 1-[3-(4-fluoro-phenyl-piperazin-1-yl]-6,7-dimethoxy-isoquinoline-4-carbonitrile, having improved solubility, metabolic stability and/or bioavailability, used for the treatment of neurodegenerative diseases, psychological disorders and drug addiction |
| 03/19/2009 | US20090075986 Anti-inflammatory medicaments |
| 03/19/2009 | US20090075985 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |
| 03/19/2009 | US20090075979 CETP Inhibitors |
| 03/19/2009 | US20090075978 Substituted propiolic acid amides and their use for producing drugs |
| 03/19/2009 | US20090075975 Arylsulfonamides and uses related thereto |
| 03/19/2009 | US20090075968 CETP inhibitors |
| 03/19/2009 | US20090074791 Phenylisoquinoline and Phenylquinazoline Derivatives |
| 03/19/2009 | US20090074675 Indazoles as glucocorticoid receptor ligands |
| 03/19/2009 | DE102007044277A1 Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln Substituted nicotinamide compounds and their use in medicaments |
| 03/19/2009 | DE102007044032A1 New substituted heteroaryl compounds are hypoxia-inducible factor prolyl-4-hydroxylase inhibitors useful to treat and/or prevent e.g. circulatory heart diseases, heart failure, anemia, chronic kidney diseases and renal failure |
| 03/19/2009 | DE102004022915B4 Indolstyryl-Verbindung zur Verwendung in Aufnahmemedien und Verfahren zu dessen Herstellung Indolstyryl compound for use in recording media and methods for its preparation |
| 03/19/2009 | CA2699464A1 Piperidine derivatives as nk3 receptor antagonists |
| 03/19/2009 | CA2699384A1 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| 03/19/2009 | CA2699383A1 Azacyclylisoquinolinone and isoindolinone derivatives as histamine-3 antagonists |
| 03/19/2009 | CA2699286A1 Piperidine derivatives as agonists of muscarinic receptors |
| 03/19/2009 | CA2697399A1 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| 03/19/2009 | CA2696948A1 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones |
| 03/18/2009 | EP2036902A2 Urea compounds active as vanilloid receptor antagonist for the treatment of pain |
| 03/18/2009 | EP2036896A1 Cyclic amine compound |
| 03/18/2009 | EP2036894A1 Aurora inhibitor |
| 03/18/2009 | EP2036893A1 Abl KINASE INHIBITOR |
| 03/18/2009 | EP2036891A2 Isoquinoline inhibitors of P38 |
| 03/18/2009 | EP2036889A2 Substituted indoles and a method for the production and use thereof |
| 03/18/2009 | EP2036561A1 Agent for overcoming resistance to anti-cancer agent |
| 03/18/2009 | EP2036554A1 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment for diabetes mellitus |
| 03/18/2009 | EP2035416A1 Substituted piperidines that increase p53 activity and the uses thereof |
| 03/18/2009 | EP2035413A2 Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors |
| 03/18/2009 | EP2035412A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 03/18/2009 | EP2035411A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia. |
| 03/18/2009 | EP2035410A1 A novel process for the preparation of esomeprazole and salts thereof |
| 03/18/2009 | EP2035409A1 Benzimidazole derivatives which are to be used as anatgonist for the cb1-receptor |
| 03/18/2009 | EP2035408A1 Sulphur-containing cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 03/18/2009 | EP2035407A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 03/18/2009 | EP2035406A1 Novel substituted-1h-quinazoline-2,4-dione derivatives, preparation method thereof and pharmaceutical composition containing the same |
| 03/18/2009 | EP2035401A2 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/18/2009 | EP2035396A2 Triazole compounds that modulate hsp90 activity |
| 03/18/2009 | EP2035394A1 2-pyrazinecarboxamide derivatives |
| 03/18/2009 | EP2035390A2 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
| 03/18/2009 | EP2035386A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 03/18/2009 | EP2035384A2 Process for synthesizing piperazine-piperidine compounds |
| 03/18/2009 | EP2035379A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 03/18/2009 | EP2035378A1 Substituted isoindoles as bace inhibitors and their use |
| 03/18/2009 | EP2035375A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 03/18/2009 | EP2035372A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 03/18/2009 | EP2034996A2 Triazole compounds that modulate hsp90 activity |
| 03/18/2009 | EP2034994A2 Nf-kappa b inhibitors and uses thereof |
| 03/18/2009 | EP2000467A9 Hydrate for medical purposes |
| 03/18/2009 | EP1765807B1 Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation |
| 03/18/2009 | EP1663987B1 Ophthalmic compositions for treating ocular hypertension |
| 03/18/2009 | EP1656346B1 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases |
| 03/18/2009 | EP1567493B1 Phenyl substituted piperidine compounds for use as ppar activators |
| 03/18/2009 | EP1539151B1 Biaryl compounds having anti-infective activity |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP1353624B1 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 03/18/2009 | EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics |
| 03/18/2009 | CN101389623A New salts of an indole derivative and their use in medicine |
| 03/18/2009 | CN101389622A Pyrimidine derivatives used as pi-3 kinase inhibitors |
| 03/18/2009 | CN101389613A Macrocyclic factor viia inhibitors useful as anticoagulants |
| 03/18/2009 | CN101389608A 5-HT7 receptor antagonists |
| 03/18/2009 | CN101389606A Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (CETP) |
| 03/18/2009 | CN101386617A Substituted tetrahydroisoquinoline derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 03/18/2009 | CN100469779C Inhibitors of interleukin-1beta converting enzyme |
| 03/18/2009 | CN100469776C Amelioration of the development of cataracts and other ophthalmic diseases |
| 03/18/2009 | CN100469769C Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/17/2009 | US7504511 e.g. N-[4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4((4-[2-(S)-(hydroxymethyl)pyrrolidin-1-yl]piperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agent |
| 03/17/2009 | US7504508 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 03/17/2009 | US7504505 Synthetic nanopores for DNA sequencing |
| 03/17/2009 | US7504504 Methods of preparing aripiprazole crystalline forms |
| 03/17/2009 | US7504500 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 03/17/2009 | US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 03/17/2009 | US7504429 Receptor or non-receptor types; 1H-pyrrole-3-carboxylates; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/17/2009 | US7504422 Polyamine compounds |
| 03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 03/17/2009 | US7504417 Substituted benzene derivatives or salts thereof |
| 03/17/2009 | US7504416 4-substituted quinolines as antitumor agents |
| 03/17/2009 | US7504414 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide |
| 03/17/2009 | US7504411 2,3,6-Trisubstituted-4-pyrimidone derivatives |
| 03/17/2009 | US7504410 such as N-[3-[[5-bromo-4-[[3-[[[1-(trifluoromethyl)cyclobutyl]carbonyl]amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide; Chks (checkpoint kinases), Akts (protein kinases B) and Pdks (phosphoinositide-dependent kinases) inhibitors; antiproliferative agents |
| 03/17/2009 | US7504402 bicyclo[2.2.2]-oct-1-yl-1,2,4-triazoles; type 2 diabetes, lipid disorders, obesity, atherosclerosis, metabolic syndrome, hyperglycemia, insulin resistance; increase insulin sensitivity in muscle, liver and adipose tissue by correction of the elevated plasma levels of glucose without causing hypoglycemia |
| 03/17/2009 | US7504401 Anti-cancer agents and uses thereof |
| 03/17/2009 | US7504400 MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles |
| 03/17/2009 | US7504393 Benzylamine analogues |